EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The ceRNA network of LINC00536/miR-204-5p/TGFBR2: A novel therapeutic target for breast cancer diagnosis and treatment

Tayier Tuersong, Munire Shataer, Dilare Lidifu, Jing Chen, Yong Bai, Linjie Lei, Xiu Zhao, Yan Chen, Shumei Feng, Liangying Ma

Cellular Signalling · 2026-01 · 137 · 112192

DOI: 10.1016/j.cellsig.2025.112192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026-01. Verfasst von Tayier Tuersong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xinjiang Key Laboratory of Neurological Diseases, Xinjiang Clinical Research Center for Nervous System Diseases, Second Affil…. Hauptthemen laut MEDLINE: Breast Neoplasms, RNA, Long Noncoding, MicroRNAs, Receptor, Transforming Growth Factor-beta Type II. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Xinjiang Uygur Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Long non-coding RNAs (lncRNAs) act as competing endogenous RNAs (ceRNAs) to regulate tumor progression, yet the role of LINC00536 in breast cancer (BC) remains unclear. This study investigates the oncogenic function,potential tumor microenvironment (TME) relevance, and molecular mechanism of LINC00536 in BC. METHODS: A pan-cancer analysis using TCGA/GTEx databases evaluated LINC00536 expression and its prognostic relevance. Functional assays (CCK-8, EdU, wound healing, colony formation) and qRT-PCR were performed in BC cell lines. Dual-luciferase reporter, Western blot, and ELISA validated the LINC005iR-204-5p/TGFBR2 axis and TGF-β pathway activation. Nude mouse xenograft and lung metastasis models assessed in vivo tumorigenicity. RESULTS: LINC00536 was overexpressed in BC tissues/cell lines and its expression correlated with a poor prognosis. High LINC00536 levels were associated with elevated stromal/immune scores and immune checkpoint gene expression, suggesting a potential role in TME modulation. Mechanistically, LINC00536 sponged miR-204-5p, thereby upregulating TGFBR2, which activated TGF-β signaling and induced epithelial-mesenchymal transition (EMT). In vitro, LINC00536 promoted proliferation, migration, and EMT, while in vivo, it accelerated tumor growth and lung metastasis (p < 0.05). Time-dependent TGF-β activation dynamics confirmed pathway regulation via the LINC00536/miR-204-5p/TGFBR2 axis. CONCLUSIONS: LINC00536 promotes BC progression and activates TGF-β signaling via miR-204-5p/TGFBR2, with its expression correlating with features of the TME, establishing its potential as a diagnostic/prognostic biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsRNA, Long NoncodingMicroRNAsReceptor, Transforming Growth Factor-beta Type IIHumansFemaleAnimalsMiceCell Line, TumorMice, NudeGene Expression Regulation, NeoplasticTumor MicroenvironmentCell ProliferationPrognosisMice, Inbred BALB CEpithelial-Mesenchymal TransitionTransforming Growth Factor betaRNA, Competitive Endogenous

Stichwörter der Autor:innen

Breast cancerLINC00536TGF-β signalingTumor microenvironmentceRNA

Substanzen

RNA, Long NoncodingMicroRNAsReceptor, Transforming Growth Factor-beta Type IITGFBR2 protein, humanMIRN204 microRNA, humanTransforming Growth Factor betaRNA, Competitive Endogenous

Autor:innen und Institutionen

  • Department of Pharmacy, Xinjiang Key Laboratory of Neurological Diseases, Xinjiang Clinical Research Center for Nervous System Diseases, Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830001, China.;…
  • Department of Histology and Embryology, Basic Medical College of Xinjiang Medical University, Urumqi 830001, China.
  • Morphologic Center, Basic Medical College of Xinjiang Medical University, Urumqi 830001, China.
  • Department of Breast Surgery, Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830001, China.
  • Department of Pharmacy, Xinjiang Key Laboratory of Neurological Diseases, Xinjiang Clinical Research Center for Nervous System Diseases, Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830001, China.
  • Department of Histology and Embryology, Basic Medical College of Xinjiang Medical University, Urumqi 830001, China. Electronic address: 87391167@qq.com.

Förderung

  • Natural Science Foundation of Xinjiang Uygur Autonomous Region

Zitieren

APA

Tuersong, T., Shataer, M., Lidifu, D., Chen, J., Bai, Y., Lei, L., Zhao, X., Chen, Y., Feng, S., & Ma, L. (2026). The ceRNA network of LINC00536/miR-204-5p/TGFBR2: A novel therapeutic target for breast cancer diagnosis and treatment. Cellular Signalling, 137, 112192. https://doi.org/10.1016/j.cellsig.2025.112192

Vancouver

Tuersong T, Shataer M, Lidifu D, Chen J, Bai Y, Lei L, et al. The ceRNA network of LINC00536/miR-204-5p/TGFBR2: A novel therapeutic target for breast cancer diagnosis and treatment. Cellular Signalling. 2026;137:112192. doi:10.1016/j.cellsig.2025.112192

BibTeX
@article{Tuersong2026,
  author = {Tuersong, Tayier and Shataer, Munire and Lidifu, Dilare and Chen, Jing and Bai, Yong and Lei, Linjie and Zhao, Xiu and Chen, Yan and Feng, Shumei and Ma, Liangying},
  title = {The ceRNA network of LINC00536/miR-204-5p/TGFBR2: A novel therapeutic target for breast cancer diagnosis and treatment},
  journal = {Cellular Signalling},
  year = {2026},
  volume = {137},
  pages = {112192},
  doi = {10.1016/j.cellsig.2025.112192}
}
Kostenlos starten →